Granahan Investment Management’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-733,803
Closed -$7.29M 184
2023
Q4
$7.29M Sell
733,803
-604,167
-45% -$4.74M 0.24% 111
2023
Q3
$10.7M Sell
1,337,970
-14,908
-1% -$150K 0.38% 82
2023
Q2
$14.9M Buy
1,352,878
+117,697
+10% +$1.21M 0.46% 64
2023
Q1
$12.8M Buy
1,235,181
+162,086
+15% +$1.91M 0.39% 73
2022
Q4
$11.8M Buy
1,073,095
+250,092
+30% +$3.21M 0.36% 79
2022
Q3
$12.8M Buy
823,003
+46,370
+6% +$1.02M 0.42% 67
2022
Q2
$17.8M Buy
776,633
+237,208
+44% +$5.07M 0.61% 41
2022
Q1
$13.3M Buy
539,425
+241,040
+81% +$5.44M 0.33% 80
2021
Q4
$8.15M Buy
+298,385
New +$10.4M 0.17% 126

Other funds holding DH

Granahan Investment Management's DH Position: Q1 2024 in Review

Granahan Investment Management sold out of Definitive Healthcare (DH) in Q1 2024, closing a stake of 733,803 shares — an estimated $7.29M sold.

Granahan Investment Management first reported a position in DH in Q4 2021 and held it in 9 quarters. The position peaked at $17.8M in Q2 2022. 144 funds tracked by Wall St. Rank hold DH as of Q1 2024.

  • Granahan Investment Management reported no remaining Definitive Healthcare position as of Q1 2024 after selling out during the quarter.
  • Granahan Investment Management sold 733,803 Definitive Healthcare shares in Q1 2024, an estimated $7.29M.
  • Granahan Investment Management first reported a position in Definitive Healthcare in Q4 2021 and held it in 9 quarters.
  • Granahan Investment Management's Definitive Healthcare position peaked at $17.8M in Q2 2022.
  • 144 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2024.

Based on Granahan Investment Management's 13F filing for Q1 2024, filed 15 May 2024.